NCT04692324View on ClinicalTrials.gov

Cerebrospinal Fluid Biomarkers for Brain Tumors

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Central Nervous System Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of CSF samples

OTHER

Electronic Health Record Review

Review of medical records

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Mayo Clinic

OTHER